While the BODIPYfluorophore had limited in vivo utility due to itssub-NIR emission profile, it was used in ex vivo fluorescenceanalysis of tumor tissue to evaluate tracer distribution.6 Similarly, Lee et al. developed a radioimmunoconjugatebased on another HER2-specific antibody, pertuzumab, configured forboth PET/CLI and NIR imaging via modification with 89Zrand IRDye800CW, respectively. The gene discussed is ERBB2; the disease is neoplasm.